依达拉奉治疗短暂性脑缺血发作45例分析

Treatment of transient ischemic attack with yidalaphon:a report of 45 cases

目的观察依拉达奉治疗短暂性脑缺血发作(TIA)的临床疗效。方法90例TIA病人随机分为两组,依拉达奉治疗组为治疗组(45例),传统治疗组为对照组(45例)。结果治疗组脑梗死发生率8.8%,TIA反复发作控制率93.2%;对照组脑梗死发生率17.6%,TIA反复发作控制率67.1%,两组比较差异有显著性(P<0.05),两组不良反应发生率无明显差异。结论依拉达奉治疗TIA能有效降低脑梗死发生率和控制TIA发作。

Aim To explore Yidalaphon＇ s efficacy in treating transient ischemic attacks （ TIA ）, to control recurrence of TIA, as well as prevent the cerebral infarction. Method 90 cases of patients with TIA were divided randomly into two groups：one group was treatment group（45 cases ） which was treated with Yidalaphon ; another was comparison group （ 45 cases ） which received traditional treatment. Resuits There is 8.3% of the cerebral infarction rate and 93.2% of recurrence rate of TIA in observation group, which is markedly lower than 17.6% and 67.1% of those in comparison group（P 〈0.05）. There is no obvious diffenence of adverse drug reantion rate in both groups. Conclusion Using Yidalaphon to treat TIA can reduce the cerebral infarction rate and control recurrence rate of TIA.